Font Size: a A A

The Value Of Platelet-lymphocyte Ratio And Neutrophil-lymphocyte Ratio In The Treatment Response And Prognosis Of Patients With Peripheral T-cell Lymphoma

Posted on:2021-02-07Degree:MasterType:Thesis
Country:ChinaCandidate:Y C ZhaoFull Text:PDF
GTID:2404330614968379Subject:Clinical medicine
Abstract/Summary:PDF Full Text Request
BackgroundPeripheral T-cell lymphoma(PTCL)is a highly heterogeneous non-Hodgkin lymphoma(NHL)subtype.To date,several prognostic models have been proposed to predict the prognosis of PTCL patients.However,the factors affecting PTCL prognosis are still not fully elucidated.Therefore,it is of great importance to seek the indicators associated with poor prognosis.MethodsA retrospective study of 213 adult patients with diagnosed PTCL in the First Affiliated Hospital of Medical School of Zhejiang University from January,2012 to December,2017 was performed.The aim is to assess the value of platelet-lymphocyte ratio(PLR)and neutrophil-lymphocyte ratio(NLR)in the treatment response and prognosis of PTCL patients.ResultsThe median age of all PTCL patients was 52 years.135 cases(63.4%,135/213)weremale and 78 cases(36.6%,78/213)were female.Patients with PLR≥232.5 achieved a lower complete response(CR)rate than patients with PLR<232.5(18.5%vs.56.6%,P<0.001).And the CR rate of patients with NLR≥3.7 was also significantly lower than that of patients with NLR<3.7(31.7%vs.60.7%,P<0.001).In the Cox univariate analysis,high PLR and high NLR were related with worse overall survival(OS).And Cox multivariate analysis suggested that PLR≥232.5,bone marrow involvement,IPI>2,decreased albumin level and ALC≤0.8×10~9/L were independent prognostic factors of PTCL patients.Then,all patients were divided into four groups according to the number of risk factors,including low risk group(zero,one or two factors),intermediate low risk group(three factors),intermediate high risk group(four factors)and high risk group(five factors),with the 3-year OS of 84.2%,41.9%,16.3%and 0.0%,respectively(P<0.001).ConclusionThis retrospective study demonstrated that high PLR and high NLR were closely associated with the treatment response and prognosis in patients with PTCL,which may improve the risk stratification and guide clinical treatment.
Keywords/Search Tags:Peripheral T-cell lymphoma, Platelet-lymphocyte ratio, Neutrophil-lymphocyte ratio, Complete response, Prognosis
PDF Full Text Request
Related items
Application Of Peripheral Blood Neutrophil-to-Lymphocyte Ratio And Platelet-to-Lymphocyte Ratio To Predict The Progression Of Advanced Non-small Cell Lung Cancer After Chemotherapy
Pretreatment Neutrophil-to-Lymphocyte Ratio,Lymphocyte-to-Monocyte Ratio And Platelet-to-lymphocyte Ratio As Predictive And Prognostic Fators For Advanced Non-small Cell Lung Cancer(NSCLC)
Prognostic Significance Of Pretreatment Neutrophil-to-Lymphocyte Ratio(NLR),Platelet-to-Lymphocyte Ratio(PLR) And Monocyte-to-Lymphocyte Ratio(MLR) In Endometrial Neoplasms:A Meta-Analysis
To Explore The Clinical Value Of Neutrophil To Lymphocyte Ratio And Platelet To Lymphocyte Ratio In Chronic Obstructive Pulmonary Disease
The Value Of Peripheral Blood Neutrophil/Lymphocyte Ratio And Platelet/Lymphocyte Ratio In Diagnosis Of Prostate Cancer
The Combination Of Neutrophil-Lymphocyte Ratio(NLR)and Platelet-Lymphocyte Ratio(PLR)Predicted Or Evaluated The Efficacy Response And Prognosis Of Patients With Advanced Non-Small Cell Lung Cancer(NSCLC)
Studies On The Relationship Between Inflammatory Index Of Platelet Lymphocyte Ratio (PLR) And Neutrophil Lymphocyte Ratio (NLR) And The Diagnosis And Prognosis Of Prostate Cancer
The Prognostic Value Of Neutrophil/Lymphocyte Ratio And Platelet/Lymphocyte Ratio In Diffuse Large B-cell Lymphoma
The Prediction Significance Of Peripheral Blood Cell Parameters For Coronary Artery Lesion In Children With Complete Kawasaki Disease In Different Age-groups
10 Effect Of Preoperative Peripheral Blood Neutrophil-to-lymphocyte Ratio And Platelet-to-lymphocyte Ratio On Diagnosis And Prognosis Of Patients With Clear Cell Renal Cell Carcinoma